Marker Therapeutics, Inc. (MRKR) vs PAVmed Inc. (PAVM)
A side-by-side comparison of Marker Therapeutics, Inc. and PAVmed Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MRKR
Marker Therapeutics, Inc.
$1.01HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
PAVM
PAVmed Inc.
$2.68HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — MRKR vs PAVM
growth of $100 · dividends reinvested · last 10yMRKR -98.3% (-33.4%/yr)PAVM -100.0% (-54.0%/yr)MRKR compounded faster over this window
Log scale — wide-divergence pair
MRKR PAVM
MRKR vs PAVM: by the numbers
- •PAVM is the larger company ($17M vs $17M market cap).
- •Both run net losses; MRKR's is the smaller (-706.23% vs -10794.64% net margin).
Metrics side by side
Valuation
| Metric | MRKR | PAVM |
|---|---|---|
| P/S ratio | 13.66 | 152.45 |
| P/B ratio | 1.38 | 0.55 |
Profitability
| Metric | MRKR | PAVM |
|---|---|---|
| Gross margin | 0.00% | -354.93% |
| Operating margin | 0.00% | -30712.68% |
| Net margin | -706.23% | -10794.64% |
| ROE | -71.57% | -34.50% |
| ROIC | -88.07% | -73.92% |
Growth (annualized)
| Metric | MRKR | PAVM |
|---|---|---|
| Total return CAGR (5Y) | -42.13% | -76.55% |
Frequently asked
- How have MRKR and PAVM total returns compared?
- Over the past 10 years, MRKR delivered -33.25% and PAVM delivered -54.03% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.